Repligen (RGEN) – Analyst Comments
-
Benchmark Steps to Sidelines on Repligen (RGEN), 'Shares Reach Price Target'
-
RBC Capital Upgrades Repligen (RGEN) to Outperform, 'Getting Off the Bioproduction Bench'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RGEN Stock Lookup